Interferon Alpha-Expressing Oncolytic Adenovirus for Treatment of Esophageal Adenocarcinoma.
Christopher J LaRoccaAmanda O SalzwedelMizuho Sato-DahlmanMargarita V RomanenkoRafael AndradeJulia DavydovaMasato YamamotoPublished in: Annals of surgical oncology (2021)
An IFN-expressing CRAd driven by the Cox2 promoter has strong oncolytic effects as well as cancer-specific replication. Our novel vector possesses critical characteristics that make it a potential candidate for clinical translation to treat EAC.